Neuroprotective Role of Nanoencapsulated Quercetin in Combating Ischemia-Reperfusion Induced Neuronal Damage in Young and Aged Rats

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Ghosh, Aparajita ^a,b   Sarkar, Sibani ^a   Mandal, Ardhendu K ^a   Das, Nirmalendu ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b BOSE INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALKADIENE; CASPASE 3; CATALASE; GLUTATHIONE; INDUCIBLE NITRIC OXIDE SYNTHASE; NANOENCAPSULATED QUERCETIN; NANOPARTICLE; POLYGLACTIN; QUERCETIN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN ISCHEMIA; CELL COUNT; CONTROLLED STUDY; DENTATE GYRUS; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; JUVENILE ANIMAL; LIPID PEROXIDATION; MALE; MITOCHONDRIAL MEMBRANE; NANOENCAPSULATION; NEUROPROTECTION; NONHUMAN; OSMOLALITY; PARTICLE SIZE; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; RAT; REPERFUSION INJURY; SINGLE DRUG DOSE; UPREGULATION; VISCOSITY;

AGING; ANIMALS; ANTIOXIDANTS; BRAIN ISCHEMIA; CASPASE 3; CELL COUNT; GLUTATHIONE; HIPPOCAMPUS; MALE; MITOCHONDRIAL MEMBRANES; NANOCAPSULES; NEURONS; NEUROPROTECTIVE AGENTS; NITRIC OXIDE SYNTHASE TYPE II; OSMOLAR CONCENTRATION; QUERCETIN; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY; VISCOSITY;

ANIMALIA; RATTUS;

EID: 84876445166     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057735     Document Type: Article

References (54)

1. Brouns R, De Deyn PP, (2009) The complexity of neurological processes in acute ischemic stroke. Clin. Neurol. Neurosurg 111: 483-495.
2. Xia Y, Dawson VL, Dawson TM, Synder SH, Zweier JL, (1996) Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite mediated cellular injury. Proc Natl Acad Sci USA 93: 6770-6774.
3. Almedia A, Bolanos JP, Medina JM, (1999) Nitric oxide mediates glutamateinduced mitochondrial depolarization in rat cortical neurons. Brain Res 816: 580-586.
4. Chrissobolis S, Faraci FM, (2008) The role of oxidative stress and NADPH oxidase in cerebrovascular disease. Trends Mol Med 14: 495-502.
5. Squire LR, Schacter DL (2002) Neuropsychology of memory 3rd Edition. New York: Guilford Press.
6. Harry GJ, Lefebvre d'Hellencourt C, (2003) Dentate gyrus: alterations that occur with hippocampal injury. Neurotox 24: 343-356.
7. Lee JC, Kim J, Park JK, Chung GH, Jang YS, (2003) The antioxidant, rather than prooxidant, activities of quercetin on normal cells: quercetin protects mouse thymocytes from glucose oxidase-mediated apoptosis. Exp Cell Res. 291(2): 386-97.
8. Havsteen B, (1983) Flavonoids, a class of natural products of high pharmacological potency. Biochem Pharmacol 32: 1141-1148.
9. Rodriguez RJ, Miranda CL, Stevens JF, Deinzer ML, Buhler DR, (2001) Influence of phenylated and non-phenylated flavonoids on liver microsomal lipid peroxidation and oxidative injury in rat hepatocytes. Food Chem Toxicol 39: 437-445.
10. Chan PH, Kawase M, Murakami K, Chen SF, Li Y, et al. (1998) Overexpression of SOD I in transgenic rats protect vulnerable neurons against ischemic damage after global cerebral ischemia and reperfusion. Jr. Neurosci 18: 8292-8299.
11. Bala I, Hariharan S, Kumar MN, (2004) PLGA nanoparticles in drug delivery: the state of the art. Crit Rev Ther Drug Carrier 21(5): 387-422.
12. Silva GA, (2008) Nanotechnology approaches to crossing the blood-brain barrier and drug delivery to the CNS. BMC Neuroscience 9(Suppl 3): S4.
13. Vergoni AV, Tosi G, Tacchi R, Vandelli AM, Bertolini A, et al. (2009) Nanoparticles as drug delivery agents specific for CNS: in vivo biodistribution. Nanomedicine: Nanotechnology, Biology, and Medicine 5: 369-377.
14. Moghimi SM, Hunter AC, Murray JC, (2001) Long-Circulating and Target-Specific Nanoparticles: Theory to Practice. Pharmacological Reviews 53: 283-318.
15. Oliver JC, (2005) Drug Transport to Brain with Targeted Nanoparticles. NeuroRx 2: 108-119.
16. Dikpati A, Madgulkar AR, Kshirsagar SJ, Bhalekar MR, Singh Chahal A, (2012) Targeted Drug Delivery to CNS using Nanoparticles. 2: 179-191.
17. Hariharan S, Bhardwaj V, Bala I, Sitterberg J, Bakowasky U, et al. (2006) Design of estradiol loaded PLGA nanoparticulate formulations: a Potential oral delivery system for hormone therapy. Pharm Res 23: 184-195.
18. Changtam C, de Koning HP, Ibrahim H, Sajid MS, Gould MK, et al. (2010) Curcuminoid analogs with potent activity against Trypanosoma and Leishmania species. Eur J Med Chem 45: 941-956.
19. Ruozi B, Tosi G, Leo E, Vandelli MA, (2007) Application of atomic force microscopy to characterize liposomes as drug and gene carriers. Talanta 73: 12-22.
20. Bors W, Heeller W, Michel C, Saran M, (1990) Flavonoids as antioxidants: determination of radical scavenging efficiencies. Meth Enzymol 186: 343-355.
21. Betainder C, Fontaine E, Keriel C, Leuerve XM, (2002) Determination of mitochondrial oxygen species: methodological aspects. J Cell Mol Med 6: 175-187.
22. Recknagel RO, Glende EA Jr, (1984) Spectrophotometric detection of lipid conjugated dienes. Meth Enzymol 105: 331-337.
23. Lowry OH, Rosebrough NJ, Farr Al, Randall RJ, (1951) Protein measurement with the folin phenol reagent. Jour Biol Chem 193: 265-275.
24. Griffith OW, (1980) Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Analyt Biochem 106: 207-212.
25. Sarkar A, Bishayee A, Chatterjee M, (1995) Beta carotene prevents lipid peroxidation and red blood cell memebrane protein damage in experimental hepatocarcinogenesis. Cancer Biochem Biophys 15: 111-125.
26. Aebi H, (1984) Catalase in vitro. Meth Enzymol 105: 121-126.
27. Marklund S, Marklund G, (1974) Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47: 469-74.
28. Rapport SI, (1978) A mathematical model for vasogenic brain edema. J Theor Biol 74: 439-467.
29. Maniatis T, Jeffrey A, Kleid DG, (1975) Nucleotide sequence of the rightward operator of phage lambda. Proc Natl Acad Sci U S A 72: 1184-1188.
30. Sarkar S, Mandal S, Sinha J, Mukhopadhyay S, Das N, et al. (2002) Quercetin: critical evaluation as an anti leishmanial agent in vivo in hamsters using different vesicular delivery modes. J Drug Target 10: 573-578.
31. Davies DC, Horwood N, Issacs SL, Mann DMA, (1992) The effect of age and alzheimer's disease on pyramidal neuron density in the individual fields of the hippocampal formation. Acta Neuropathol 83: 510-517.
32. Davies KJ, (2001) Degradation of oxidized proteins by the 20S proteasome. Biochimie 83: 301-310.
33. Dogru Abbasoglu Tamer-Toptani S, Uǧurnal B, Koçak-Toker N, Aykaç-Toker G, Uysal M, (1997) Lipid peroxidation and antioxidant enzymes in livers and brains of aged rats. Mech Ageing Dev 98: 177-180.
34. Evans PH, (1993) Free radicals in brain metabolism and pathology. Brit Med Bull 49: 577-587.
35. Silva GA, (2008) Nanotechnology approaches to crossing the blood-brain barrier and drug delivery to the CNS. BMC Neuroscience 9(Suppl 3): S4.
36. Taylor CP, Weber ML, Gaughan CL, Lehning EJ, LoPachin RM, (1999) Oxygen/Glucose Deprivation in Hippocampal Slices: Altered Intraneuronal Elemental Composition Predicts Structural and Functional Damage. The Journal of Neuroscience 19: 619-629.
37. Kirino T, (1982) Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res 239: 57-69.
38. Horn M, Schlote W, (1992) Delayed neuronal death and delayed neuronal recovery in the human brain following global ischemia. Acta Neuropathol 85: 79-87.
39. Lockman PR, Mumper RJ, Khan MA, Allen DD, (2002) Nanoparticle technology for drug delivery across the blood-brain barrier. Drug Dev Ind Pharm 28: 1-13.
40. Kong LD, Zhang Y, Pan X, Tan RX, Cheng CH, (2000) Inhibition of xanthine oxidase by liquiritigenin and isoliquiritigenin isolated from Sinofranchetia chinensis Cell Mol. Life Sci 57: 500-505.
41. Chen J, Jin K, Chen M, Pei W, Kawaguchi K, et al. (1997) Early detection of DNA strand breaks in the brain after transient focal ischemia: implications for the role of DNA damage in apoptosis and neuronal cell death. J. Neurochem 69: 232-245.
42. McKracken V, Valeriani C, Simpson T, Jover J, Dewar MD (2000) The lipid peroxidation by-product 4-hydroxynonenal is toxic to axons and oligodendrocytes. J. Cereb. Blood Flow Metab. 20, 1529-1536.
43. Claude P, Zhang J, (1996) Mitochondrial Generation of Reactive Oxygen Species After Brain Ischemia in the Rat. Stroke 27: 327-332.
44. Nordberg J, Arnér ESJ, (2001) Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radical Biology & Medicine 31: 1287-1312.
45. Kontos HA, George E, (1985) Brown Memorial Lecture: oxygen radicals in cerebral vascular injury. Circ Res 57: 508-516.
46. Glinsberg MD, Pulsinelli WA, (1994) The ischemic penumbra, injury thresholds, and the therapeutic window for acute stroke [editorial comment]. Ann Neurol 36: 553-554.
47. Lee H, Bae JH, Lee SR, (2004) Protective effect of green tea polyphenol EGCG against neuronal damage and brain edema after unilateral cerebral ischemia in gerbils. J Neurosci 77: 892-900.
48. Issa AM, Rowe W, Gauthier S, Meaney MJ, (1990) Hypothalamic-pituitaryadrenal activity in aged, cognitively impaired and cognitively unimpaired rats. J Neurosci 10: 3247-3254.
49. Zhu D, Tan KS, Zhang X, Sun AY, Sun GY, et al. (2005) Hydrogen peroxide alters membrane and cytoskeleton properties and increases intercellular connections in astrocytes. J Cell Sci. 2005 118: 3695-703.
50. Abe K, Aoki M, Kawagoe J, Yoshida T, Hattori A, et al. (1995) Ischemic Delayed Neuronal Death: A Mitochondrial Hypothesis. Stroke 26: 1478-1489.
51. Meaney MJ, Aitken DH, van Berkel C, Bhatnagar S, Sapolsky RM, (1988) Effect of neonatal handling on age-related impairments associated with the hippocampus. Science 239: 766-768.
52. Earnshaw WC, (1995) Nuclear changes in apoptosis. Current Opinions in Cell Biology 7: 337-43.
53. Hartmann A, Hunot S, Michel PP, Muriel MP, Vyas S, et al. (2000) Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease. PNAS 97: 2875-2880.
54. Gross SS, Wolin MS, (1995) Nitric oxide: pathophysiological mechanisms. Annu Rev Physiol 57: 737-769.